3rd Quarter - Report — HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION (2024)

Firm

HOOPER, LUNDY & BOOKMAN, P.C.

Client

ROCHE DIAGNOSTICS CORPORATION

Income

$30,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.

Lobbyist	Covered position, as disclosed
LISA LAYMAN	SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2369 (118th)

Medicare/Medicaid MMM

S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

Lobbyist	Covered position, as disclosed
LISA LAYMAN	SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2377 (118th), H.R. 1691 (118th), S. 1000 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.